Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Rokycany

8 clinical trials in Rokycany, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Rokycany at a glance
8
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Rokycany

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
  • Sponsor:Upstream Bio Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate Anhydrous
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Rokycany

What the registry says about research in the country

01 COPD Research

Innovative clinical trials focusing on chronic obstructive pulmonary disease are evaluating new combination therapies. Studies examine triple therapy combinations against dual bronchodilators to improve cardiopulmonary outcomes.

  • Triple therapy effectiveness
  • Lung function improvement
  • Cardiopulmonary outcomes

Research aims to enhance treatment options for patients with moderate to very severe COPD presentations.

02 Severe Asthma Studies

Advanced research into severe and inadequately controlled asthma is evaluating novel combination inhalers. These trials focus on improving lung function and reducing asthma exacerbations in patients not responding to standard treatments.

  • Combination inhaler therapy
  • Exacerbation prevention
  • Treatment resistance

Studies target both adult and adolescent populations with persistent symptoms.

03 Respiratory Medicine Advances

Current investigations in respiratory therapeutics are exploring the efficacy of various inhaler combinations. Research includes assessment of treatments for patients with elevated blood eosinophils and frequent exacerbations.

  • Biomarker-guided therapy
  • Exacerbation management
  • Treatment optimization

These studies aim to provide more personalized treatment approaches for respiratory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.